Bangladesh's Measles Outbreak

Source: The Hindu| Date: April 6, 2026 

Bangladesh is facing its worst measles outbreak in recent memory. Since 15 March 2026, over 7,500 suspected cases and 100+ deaths have been recorded; compared to just 125 confirmed cases across all of 2025. The rapid acceleration points to a systemic breakdown in immunisation coverage, exposing years of accumulated public health vulnerabilities beneath the surface of a country with an otherwise strong vaccination record.

The scale of deterioration in a matter of weeks is not merely alarming in human terms; it signals that herd immunity, the critical threshold needed to prevent community spread, has been seriously compromised across key population segments.

Key Findings

→ The Infant Vulnerability Crisis

Perhaps the most clinically alarming dimension of this outbreak is its impact on the youngest demographic. Approximately one-third of infected patients are infants under nine months old; children who are not yet eligible for routine vaccination under Bangladesh's national immunisation schedule. This is not simply a statistic; it is a public health red flag.

When unvaccinated infants contract measles in large numbers, it indicates that herd immunity in surrounding communities has collapsed below the WHO's recommended 95% threshold. Vaccinated adults and older children are no longer providing an effective buffer of protection. The virus is finding unprotected hosts in the most vulnerable population.

→ The Vaccination Gap — A Decade in the Making

• No special measles vaccination campaigns have been held since 2020; a six-year gap in a programme designed to run every four years.
• Covid-19 disrupted the first planned post-2020 campaign, pushing it beyond its scheduled window.
• Bangladesh's 2024 political upheaval; which saw Prime Minister Sheikh Hasina ousted following mass protests; further derailed institutional functioning, including health administration.
• A campaign planned for April 2026 was cancelled due to procurement failures and vaccine shortages under the outgoing interim administration.
• The new elected government, in power only since February 2026, inherited a broken supply chain before it could prevent the outbreak.

→ Cox's Bazar: A Hotspot Within a Hotspot

Cox's Bazar, in southeastern Bangladesh, hosts one of the world's most densely populated refugee settlements; the Rohingya camps, home to approximately one million displaced people. Measles spreads with exceptional efficiency in overcrowded, poorly ventilated environments with limited access to healthcare. The targeting of Cox's Bazar in the emergency campaign is both necessary and urgent.

Containment failure in these camps could accelerate transmission exponentially, making the camp population simultaneously a victim of neglect and a potential vector of wider spread.

Root Causes — A Governance Failure, Not a Medical Mystery

This outbreak is not the product of a sudden or unexpected pathogen. Measles is entirely preventable. Its re-emergence in Bangladesh reflects the direct consequences of sustained institutional failure across multiple governments and administrations. The causal chain is traceable and damning:

• The Hasina government's political troubles and eventual collapse disrupted government functioning, including health procurement and campaign logistics.
• The interim administration, which took over following Hasina's ousting in mid-2024, restructured the vaccine procurement system. Critics argue this created new inefficiencies and supply gaps rather than fixing old ones.
• The April 2026 vaccination campaign; the most immediate line of defence, was cancelled at the worst possible time, just as the epidemiological window for outbreak prevention was closing.

As UNICEF observed, measles resurgences are typically the product of accumulated immunity gaps over time rather than a single event. Bangladesh's vaccination coverage, while historically strong, was quietly eroded through a combination of Covid-era disruption, political instability, and administrative failure. The outbreak is the visible result of invisible decay.

Response Measures

Bangladesh moved swiftly once the outbreak reached crisis level, launching an emergency measles and rubella vaccination campaign with international support. The response includes:

• An emergency immunisation drive targeting 1.2 million children aged 6 months to 5 years across 30 sub-districts (upazilas).
• Prioritisation of children who missed routine immunisation and are at highest risk of severe complications.
• Special focus on Dhaka — the densely populated capital — and Cox's Bazar, where risk of rapid community spread is highest.
• Active support from UNICEF and the World Health Organization (WHO), who are providing technical and logistical assistance.
• Public awareness campaigns, including infographics on measles identification, symptoms, and prevention, to address community-level knowledge gaps.

The response is appropriate in direction, but its speed and reach will determine its effectiveness. Children under six months; the most medically fragile; remain outside the scope of even the emergency vaccination protocol, meaning broader community immunity must be restored rapidly to protect this group by proxy.

Global Context — Bangladesh in a Wider Resurgence

Bangladesh's crisis does not exist in isolation. The Lancet has flagged 2024-2025 as having the highest measles outbreak count globally in more than two decades. The WHO has sounded similar warnings about a worldwide resurgence, driven by different but converging forces across regions.

Two distinct resurgence patterns are visible globally:

• Western Nations (US, UK, parts of Europe): Rising vaccine hesitancy, amplified by pandemic-era distrust of public health institutions, is driving outbreaks in countries that previously had near-total immunisation coverage.
• South and Southeast Asia, Sub-Saharan Africa: Institutional and logistical failure — not hesitancy — is the primary driver. Supply chain breakdowns, political instability, and underfunded health systems are creating coverage gaps that the virus exploits.

Bangladesh fits firmly in the second category. Its crisis is a governance problem, which is both more correctable and more politically accountable than cultural attitudes toward vaccines. Whether the new elected government treats this as a systemic wake-up call; rather than a one-time emergency; will determine whether such outbreaks recur.

Critical Assessment

Several dimensions of this crisis warrant particular scrutiny:

→ What Worked

• Bangladesh's baseline vaccination infrastructure — built over decades — has generally maintained relatively high coverage, which is why the current breakdown stands out as an anomaly rather than a norm.
• The emergency response has been reasonably prompt once the scale of the outbreak became clear, with international partners rapidly mobilised.

→ What Failed

• The political system failed to insulate the health procurement machinery from administrative disruption. Vaccines are not partisan; their supply should not be contingent on government stability.
• The April 2026 campaign cancellation represents a critical, preventable policy failure. At the time of cancellation, immunity gaps were already present; the campaign was the last realistic firewall.
• Surveillance and early warning systems appear to have failed to trigger a pre-emptive response before cases reached outbreak scale.

→ What Remains Uncertain

• The true case count is likely higher than reported. In communities with limited healthcare access, mild cases go undetected and unreported.
• The death toll of 100+ may similarly be an undercount, particularly in rural areas and refugee camps.
• Whether the emergency campaign will reach its 1.2 million target before the outbreak peaks is the central unknown.

Conclusion

Bangladesh's measles outbreak is a case study in how political and administrative failure translates directly into preventable death. Measles is not a disease of medical uncertainty; it is entirely vaccine-preventable. Every death in this outbreak represents a failure of governance, procurement, or implementation, not a failure of science.

The emergency response is necessary and overdue. But its success will be measured not only in cases prevented over the coming weeks, but in whether Bangladesh rebuilds its immunisation system with the resilience to withstand the next period of political disruption; because disruption, in any country, is not a question of if but when.